Skip to main content
Log in

Zur Therapie des fortgeschrittenen Peniskarzinoms

Brauchen wir neue Wege in der Chemotherapie?

Treatment of advanced penile cancer

Do we need new methods for chemotherapy?

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Das Peniskarzinom ist ein Plattenepithelkarzinom mit hoher Letalität im fortgeschrittenen Stadium. Es existieren nur wenige Daten aus relativ kleinen Serien zur systemischen Therapie. Die etablierten Therapieschemata sind gekennzeichnet durch hohe Toxizität und geringe Effektivität. Diese desolate Situation lässt sich nur durch systematische Studien mit neuen Therapieprotokollen ändern. Erste Ergebnisse mit neuen Substanzen sind durchaus Erfolg versprechend, gegenwärtig aber überwiegend auf die Darstellung einzelner Fälle beschränkt.

Abstract

Penile cancer is a squamous epithelial neoplasia with a very high mortality in advanced stages. Only few series with small patient numbers have addressed the systemic treatment of advanced penile carcinoma. Established regimens are characterized by high toxicity and poor efficacy. Due to the relative paucity of data, recommendations and guidelines on the treatment of metastatic penile carcinoma are vague. New approaches and large-scale studies that will allow better definition of adequate and more effective treatment options are needed. Encouraging results with newer chemotherapeutic agents are at present mainly anecdotal but are still encouraging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Dexeus FH, Logothetis CJ, Sella A et al. (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146(5): 1284–1287

    PubMed  CAS  Google Scholar 

  2. Haas GP, Blumenstein BA, Gagliano RG et al. (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 161(6): 1823–1825

    Article  PubMed  CAS  Google Scholar 

  3. Corral DA, Sella A, Pettaway CA et al. (1998) Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 160(5): 1770–1774

    Article  PubMed  CAS  Google Scholar 

  4. Hakenberg OW, Nippgen JGW, Froehner M et al. (2006) Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 98(6): 1225–1227

    Article  PubMed  CAS  Google Scholar 

  5. Solsona E, Algaba F, Horenblas S et al. (2004) EAU Guidelines on Penile Cancer. Eur Urol 46(1): 1–8

    Article  PubMed  CAS  Google Scholar 

  6. Pizzocaro G, Piva L (1998) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27(6b): 823–824

    Article  Google Scholar 

  7. Shammas FV, Ous S, Fossa SD (1992) Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 147(3): 630–632

    PubMed  CAS  Google Scholar 

  8. Long HJ (2007) 3rd Management of metastatic cervical cancer: review of the literature. J Clin Oncol 25(20): 2966–2974

    Article  PubMed  CAS  Google Scholar 

  9. Murdoch D (2007) Standard and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review. Curr Opin Oncol 19(3): 216–221

    Article  PubMed  Google Scholar 

  10. Joerger M, Warzinekb T, Klaeserc B et al. (2004) Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 63(4): 778–780

    Article  PubMed  CAS  Google Scholar 

  11. Bermejo C, Busby J, Spiess P et al. (2007) Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177(4): 1335–1338

    Article  PubMed  Google Scholar 

  12. Theodore C, Skoneczna I, Bodrogi I et al. (2008) A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 19(7): 1304–1307

    Article  PubMed  CAS  Google Scholar 

  13. Kattan J, Culine S, Droz JP et al. (1993) Penile cancer chemotherapy: twelve years‘ experience at Institut Gustave-Roussy. Urology 42(5): 559–562

    Article  PubMed  CAS  Google Scholar 

  14. Hussein AM, Benedetto P, Sridhar KS (1990) Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65(3): 433–438

    Article  PubMed  CAS  Google Scholar 

  15. Hakenberg OW, Wirth MP (1999) Issues in the treatment of penile carcinoma. A short review. Urol Int 62(4): 229–233

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O.W. Hakenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Protzel, C., Klebingat, HJ. & Hakenberg, O. Zur Therapie des fortgeschrittenen Peniskarzinoms. Urologe 47, 1229–1232 (2008). https://doi.org/10.1007/s00120-008-1841-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-008-1841-z

Schlüsselwörter

Keywords

Navigation